Serum ferritin levels do not predict the stage of underlying non-alcoholic fatty liver disease

Journal of Gastrointestinal and Liver Diseases

Volumn 21, Issue 1, 2012, Pages 53-58

  Chandok, Natasha ^a   Minuk, Gerald ^b   Wengiel, Matias ^b   Uhanova, Julia ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Cirrhosis; Ferritin; Liver steatosis; Non alcoholic fatty liver disease (NAFLD)

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FERRITIN;

ADULT; AGE; ARTICLE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; HISTOLOGY; HUMAN; HYPERFERRITINEMIA; HYPERTENSION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; RADIOLOGY; SPLENOMEGALY; STEATOSIS;

ADULT; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FATTY LIVER; FEMALE; FERRITINS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 84858825405     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010; 28: 155-161.
2. Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140: 124-131.
3. Speliotes EK, Massaro JM, Hoffmann U, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010; 51: 1979-1987.
4. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363: 1341-1350.
5. Caldwell S, Argo C. The natural history of non-alcoholic fatty liver disease. Dig Dis 2010; 28: 162-168.
6. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34:274-285.
7. Gaia S, Carenzi S, Barilli AL, et al. Reliability of transient elastography for the detection of fbrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011; 54: 64-71.
8. Myers RP, Elkashab M, Ma M, Crotty P, Pomier-Layrargues G. Transient elastography for the noninvasive assessment of liver fbrosis: a multicentre Canadian study. Can J Gastroenterol 2010; 24: 661-670.
9. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011; 259: 749-756.
10. Ratziu V, Massard J, Charlotte F, et al. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fbrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2006; 6: 6.
11. Lassailly G, Caiazzo R, Hollebecque A, et al. Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for J liver injury in patients with morbid obesity. Eur J Gastroenterol Hepatol 2011; 23: 499-506.
12. Balla J, Vercellotti GM, Jeney V, et al. Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. Antioxid Redox Signal 2007; 9: 2119-2137.
13. Canbakan B, Senturk H, Tahan V, et al. Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease. Acta Gastroenterol Belg 2007; 70: 277-284.
14. Puljiz Z, Stimac D, Kovac D, et al. Predictors of nonalcoholic steatohepatitis in patients with elevated alanine aminotransferase activity. Coll Antropol 2010; 34 Suppl 1: 33-37.
15. Valenti L, Moscatiello S, Vanni E, et al. Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study. QJM 2011; 104: 141-149.
16. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-1362.
17. Younossi ZM, Gramlich T, Bacon BR, et al. Hepatic iron and nonalcoholic fatty liver disease. Hepatology 1999; 30: 847-850.
18. Lonardo A, Loria P, Leonardi F, et al. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. Dig Liver Dis 2002; 34: 204-211.
19. Malaguarnera L, Madeddu R, Palio E, Arena N, Malaguarnera M. Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients. J Hepatol 2005; 42: 585-591.